These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30972787)

  • 1. Score tests based on a finite mixture model of Markov processes under intermittent observation.
    Jiang S; Cook RJ
    Stat Med; 2019 Jul; 38(16):3013-3025. PubMed ID: 30972787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Composite likelihood for joint analysis of multiple multistate processes via copulas.
    Diao L; Cook RJ
    Biostatistics; 2014 Oct; 15(4):690-705. PubMed ID: 24719283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of interval-censored recurrent event processes subject to resolution.
    Shen H; Cook RJ
    Biom J; 2015 Sep; 57(5):725-42. PubMed ID: 26148993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A two-phase model for chronic disease processes under intermittent inspection.
    Wu Y; Cook RJ
    Stat Med; 2017 Jun; 36(13):2016-2031. PubMed ID: 28238209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A conditional Markov model for clustered progressive multistate processes under incomplete observation.
    Cook RJ; Yi GY; Lee KA; Gladman DD
    Biometrics; 2004 Jun; 60(2):436-43. PubMed ID: 15180669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independence conditions and the analysis of life history studies with intermittent observation.
    Cook RJ; Lawless JF
    Biostatistics; 2021 Jul; 22(3):455-481. PubMed ID: 31711113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bias in progression-free survival analysis due to intermittent assessment of progression.
    Zeng L; Cook RJ; Wen L; Boruvka A
    Stat Med; 2015 Oct; 34(24):3181-93. PubMed ID: 26011411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of interval-censored disease progression data via multi-state models under a nonignorable inspection process.
    Chen B; Yi GY; Cook RJ
    Stat Med; 2010 May; 29(11):1175-89. PubMed ID: 20437455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. State selection in Markov models for panel data with application to psoriatic arthritis.
    Thom HH; Jackson CH; Commenges D; Sharples LD
    Stat Med; 2015 Jul; 34(16):2456-75. PubMed ID: 25739994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computation of the asymptotic null distribution of goodness-of-fit tests for multi-state models.
    Titman AC
    Lifetime Data Anal; 2009 Dec; 15(4):519-33. PubMed ID: 19882350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marker-dependent observation and carry-forward of internal covariates in Cox regression.
    Cook RJ; Lawless JF; Xie B
    Lifetime Data Anal; 2022 Oct; 28(4):560-584. PubMed ID: 35725841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonparametric estimation of transition probabilities in the non-Markov illness-death model: A comparative study.
    de Uña-Álvarez J; Meira-Machado L
    Biometrics; 2015 Jun; 71(2):364-75. PubMed ID: 25735883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fitting and interpreting continuous-time latent Markov models for panel data.
    Lange JM; Minin VN
    Stat Med; 2013 Nov; 32(26):4581-95. PubMed ID: 23740756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonparametric analysis of dependently interval-censored failure time data.
    Zhu Y; Lawless JF; Cotton CA
    Stat Med; 2018 Sep; 37(21):3091-3105. PubMed ID: 29766531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-state Markov models for disease progression in the presence of informative examination times: an application to hepatitis C.
    Sweeting MJ; Farewell VT; De Angelis D
    Stat Med; 2010 May; 29(11):1161-74. PubMed ID: 20437454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multistate analysis from cross-sectional and auxiliary samples.
    Zeng L; Cook RJ; Lee J
    Stat Med; 2020 Feb; 39(4):387-408. PubMed ID: 31820469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penalized regression for interval-censored times of disease progression: Selection of HLA markers in psoriatic arthritis.
    Wu Y; Cook RJ
    Biometrics; 2015 Sep; 71(3):782-91. PubMed ID: 25773729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multistate models for the natural history of cancer progression.
    Cheung LC; Albert PS; Das S; Cook RJ
    Br J Cancer; 2022 Oct; 127(7):1279-1288. PubMed ID: 35821296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flexible multistate models for interval-censored data: Specification, estimation, and an application to ageing research.
    Machado RJM; van den Hout A
    Stat Med; 2018 May; 37(10):1636-1649. PubMed ID: 29383740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonparametric regression of state occupation, entry, exit, and waiting times with multistate right-censored data.
    Mostajabi F; Datta S
    Stat Med; 2013 Jul; 32(17):3006-19. PubMed ID: 23225570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.